Cardinal Health

Pharmaceuticals
CAH
$ 69 (0.62)%
Share price
$ 18 bn
Market Cap
$ 20 bn
Enterprise Value

Carbon footprint

21 Ton
GHG emissions per $ 1 mln investment
0.55x the weighted average for S&P 500
FY2021
How is this calculated?
-4.9%
YOY change in GHG emissions
Weaker than the +5% weighted average for S&P 500
FY2021 vs. previous year

Primary Climate Goal

-4.3%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Weaker than the -6.6% weighted average for S&P 500
FY2022
How is this calculated?

Cardinal Health aims to reduce Scope 1 + 2 by 50% by 2030 from a base year 2019


This target has not been verified as science based according to SBTi
Cardinal Health's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

GHG emissions and Carbon intensity

Cardinal Health's GHG emissions (location-based) (Kt of CO2e)
Cardinal Health's Carbon intensity (Tons per 1 USDm)

Cardinal Health's carbon footprint

Cardinal Health reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 30 June 2021 at 421 Kt (-22 /-4.9% y-o-y). Also positively, carbon intensity was down at 2.6 t (-0.3 /-10.3% y-o-y).

Cardinal Health's Scope 3 emissions plummeted to 2.5 Kt (-8.5 /-77.3% y-o-y). The decline accelerated compared to the CAGR of -42.6% since 2Q'18.

The company is committed to reducing Scope 1 + 2 by 50% by 2030 from a base year 2019, which translates into the estimated reduction of -18 Kt per annum over the period of FY2022 - FY2030. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.

Company environmental metrics

Show more...